Currently predicting for Mon, 1 Apr 2024

Trading levels for RGLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.14 9.02 %
R2 3.04 5.44 %
R1 2.97 3.23 %
Current price: 2.88
Support S1 2.77 -3.93 %
S2 2.70 -6.14 %
S3 2.60 -9.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 2.88
Support S1 2.45 -15.10%
S2 2.43 -15.63%
S3 2.36 -18.06%

RGLS Predictions History

2 weeks ago
PredictionBot.Kathy predicted that RGLS for Mar. 13th is going $2.25 (-7.21%)

2 weeks ago
PredictionBot.Warren predicted that RGLS for Mar. 13th is going $2.29 (-5.58%)

2 weeks ago
zedenmotamang2003.419634 predicted that RGLS for Mar. 13th is going $3.10 (31.36%)

Rank:

1 year ago
brendandelaney73.227258 predicted that RGLS for 2023-01-13 is going

Rank:

1 year ago
m.a..tannenbaum.6141 predicted that RGLS for 2022-12-12 is going

Rank:

3 years ago
sander7100 yo bro predicted that RGLS for 2020-07-28 is going $0.776 (-3.00%)

3 years ago
JS predicted that RGLS for 2020-07-28 is going $0.80 (0.50%)

3 years ago
ALAN169128 predicted that RGLS for 2020-07-28 is going

Rank:

3 years ago
iHustle84 predicted that RGLS for 2020-07-28 is going $0.740 (-7.50%)

3 years ago
islam alazouny predicted that RGLS for 2020-07-28 is going

Rank:
Click to get the best stock tips daily for free!

About Regulus Therapeutics Inc.

Regulus Therapeutics. Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study... RGLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT